2,5-dimethoxy-4-methylamphetamine: clinical evaluation of a new hallucinogenic drug.
D000328:Adult; D000704:Analysis of Variance; D001007:Anxiety / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002986:Clinical Trials as Topic; D003192:Compulsive Behavior / Q000187:drug effects; D003863:Depression / Q000187:drug effects; D005059:Euphoria; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008950:MMPI; D008297:Male; D010919:Placebos; D011581:Psychological Tests; D011674:Pulse / Q000187:drug effects; D011680:Pupil / Q000187:drug effects
D006213:Hallucinogens; D010919:Placebos